Background Due to technical limitations of commonly used tonometry devices, the effects of physical exercise on intraocular ...

Gland Pharma has received USFDA approval for its generic Latanoprostene Bunod Ophthalmic Solution, intended to treat high eye ...

Palatin Technologies, Inc. (NYSE American: PTN), a biopharmaceutical company advancing innovative treatments targeting the ...

DelveInsight's "YUTIQ Market Size, Forecast, and Market Insight Report" highlights the details around YUTIQ, a sterile ...

Pykus Therapeutics reveals promising results for PYK-2101, a retinal sealant that enhances recovery and improves patient ...

Gland Pharma receives USFDA approval for its generic Latanoprostene Bunod Ophthalmic Solution, a bioequivalent to Bausch and ...

The FDA has expanded the approval of Dextenza (dexamethasone ophthalmic insert) to include pediatric treatment.

High blood pressure frequently occurs in people with diabetes. Learn about the relationship, risks, and treatments for ...

Verana Health’s newly launched Qdata Cataract offers a comprehensive dataset to improve outcomes, reduce complications and ...

“Ocular migraine” is a term used to cover ... For example, the pain from a tension headache — the most common form of headache — will be mild to moderate. Tension headaches tend to be ...

YUTIQ addresses a significant unmet need in the treatment of chronic non-infectious uveitis affecting the posterior segment of the eye. The uveitis treatment market is projected to grow steadily ...